EW : Edwards Lifesciences stock forecast, predictions, and share price target 2025 - 2026 - 2030 - 2035 with analysis
| year | Average | Low | High | Change from close on 2025-03-26 |
|---|---|---|---|---|
| 2025 | $81.82 | $73.62 | $90.01 | 15.09% |
| 2026 | $108.45 | $93.07 | $125.03 | 52.56% |
| 2027 | $137.64 | $127.79 | $147.83 | 93.61% |
| 2028 | $127.87 | $91.04 | $147.92 | 79.87% |
| 2029 | $72.27 | $68.26 | $83.81 | 1.66% |
| 2030 | $83.55 | $74.52 | $90.77 | 17.53% |
| 2031 | $97.55 | $87.28 | $106.36 | 37.22% |
| 2032 | $124.61 | $107.83 | $142.21 | 75.29% |
| 2033 | $141.04 | $130.16 | $144.35 | 98.4% |
| 2034 | $87.04 | $65.69 | $124.4 | 22.43% |
| 2035 | $69.34 | $67.73 | $70.93 | -2.46% |
The 27 Wall Street analysts offering Edwards Lifesciences stock forecast in the last 6 months have average price target of
$76.33 with a high forecast of $90.0 and a low forecast of $60.0.
The average Edwards Lifesciences stock forecast represents a 7.37%
increase from the last price of $71.0899963378906.
For Edwards Lifesciences stock forecast for 2025, 9 predictions are offered for each month of 2025 with average Edwards Lifesciences stock
forecast of $81.82, a high forecast of $90.01, and a low forecast of $73.62.
The average Edwards Lifesciences stock forecast 2025 represents a 15.09%
increase from the last price of $71.0899963378906.
For Edwards Lifesciences stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Edwards Lifesciences stock
forecast of $108.45, a high forecast of $125.03, and a low forecast of $93.07.
The average Edwards Lifesciences stock forecast 2026 represents a 52.56%
increase from the last price of $71.0899963378906.
For Edwards Lifesciences stock forecast for 2028, 12 predictions are offered for each month of 2028 with average Edwards Lifesciences stock
forecast of $127.87, a high forecast of $147.92, and a low forecast of $91.04.
The average Edwards Lifesciences stock forecast 2028 represents a 79.87%
increase from the last price of $71.0899963378906.
For Edwards Lifesciences stock forecast for 2030 (5 year), 12 predictions are offered for each month of 2030 with average Edwards Lifesciences stock
forecast of $83.55, a high forecast of $90.77, and a low forecast of $74.52.
The average Edwards Lifesciences stock forecast 2030 represents a 17.53%
increase from the last price of $71.0899963378906.
For Edwards Lifesciences stock forecast 2031, 12 predictions are offered for each month of 2031 with average Edwards Lifesciences stock
forecast of $97.55, a high forecast of $106.36, and a low forecast of $87.28.
The average Edwards Lifesciences stock forecast 2031 represents a 37.22%
increase from the last price of $71.0899963378906.
For Edwards Lifesciences stock forecast for 2035 (10 year), 3 predictions are offered for each month of 2035 with average Edwards Lifesciences stock
forecast of $69.34, a high forecast of $70.93, and a low forecast of $67.73.
The average Edwards Lifesciences stock forecast 2035 represents a -2.46%
decrease from the last price of $71.0899963378906.
Please, see more forecasts below.
EW : Edwards Lifesciences stock forecast by Wall Street Analysts
The average Edwards Lifesciences stock forecast from last 6 month is $76.33, and this show a 1.9% increase in average from the prior price target of the each prediction. Also, this average forecast of $76.33 represents a -12.49% decrease from the past average forecast of $87.22, 6 months ago from 37 wall street analysts.
| Date | Firm | previous price target | current price target | current rating |
|---|---|---|---|---|
| 2025-02-13 | Canaccord Genuity | $68.00 | $71.0000 | Hold |
| 2025-02-13 | Barclays | $88.00 | $90.0000 | Overweight |
| 2025-02-12 | Morgan Stanley | $70.00 | $75 | Equal-Weight |
| 2025-02-12 | Evercore ISI Group | $75.0000 | $73 | In-Line |
| 2025-02-12 | Piper Sandler | $70.00 | $73 | Neutral |
| 2025-02-12 | RBC Capital | $85.0000 | $85 | Outperform |
| 2025-01-30 | Stifel | $75.00 | $90 | Buy |
| 2025-01-16 | Wolfe Research | $60.0000 | $60.0000 | Underperform |
| 2024-12-16 | B of A Securities | $82.0000 | $90 | Buy |
| 2024-12-11 | Citigroup | $81.0000 | $83.0000 | Buy |
| 2024-12-05 | Canaccord Genuity | $63.00 | $68.0000 | Hold |
| 2024-12-05 | RBC Capital | $80.00 | $85.0000 | Outperform |
| 2024-12-05 | Stifel | $70.00 | $75 | Hold |
| 2024-12-05 | Truist Securities | $70.00 | $78 | Hold |
| 2024-12-05 | Goldman Sachs | $81.0000 | $90 | Buy |
| 2024-12-02 | Barclays | $85.0000 | $88.0000 | Overweight |
| 2024-11-27 | RBC Capital | $75.00 | $80.0000 | Outperform |
| 2024-10-25 | Baird | $73.0000 | $68 | Neutral |
| 2024-10-25 | Truist Securities | $71.00 | $70 | Hold |
| 2024-10-25 | Piper Sandler | $73.00 | $70 | Neutral |
| 2024-10-25 | JP Morgan | $72.00 | $78.0000 | Neutral |
| 2024-10-25 | Canaccord Genuity | $66.00 | $63.0000 | Hold |
| 2024-10-11 | Morgan Stanley | $70 | Equal-Weight | |
| 2024-10-08 | RBC Capital | $85.00 | $75.0000 | Outperform |
| 2024-10-07 | Canaccord Genuity | $77.00 | $66.0000 | Hold |
| 2024-10-01 | Citigroup | $83.0000 | $77.0000 | Buy |
| 2024-10-01 | Evercore ISI Group | $76.00 | $70 | In-Line |
| 2024-09-18 | Jefferies | $85.0000 | $70.0000 | Hold |
| 2024-09-13 | Truist Securities | $82.00 | $71 | Hold |
| 2024-09-12 | Oppenheimer | $90.00 | $90 | Outperform |
| 2024-09-10 | UBS | $90.0000 | $75.0000 | Neutral |
| 2024-09-09 | Barclays | $90.00 | $80.0000 | Overweight |
| 2024-09-09 | Wells Fargo | $90.00 | $80.0000 | Overweight |
| 2024-07-29 | Wolfe Research | Peer Perform | ||
| 2024-07-26 | Goldman Sachs | $107.00 | $91 | Buy |
| 2024-07-26 | Barclays | $101.00 | $90.0000 | Overweight |
| 2024-07-25 | TD Cowen | $100.0000 | $70.0000 | Hold |
| 2024-07-25 | Wells Fargo | $99.00 | $90.0000 | Overweight |
| 2024-07-25 | Evercore ISI Group | $91.00 | $76 | In-Line |
| 2024-07-25 | Deutsche Bank | $103.00 | $85 | Buy |
| 2024-07-25 | RBC Capital | $101.00 | $85 | Outperform |
| 2024-07-25 | Truist Securities | $110.00 | $82 | Hold |
| 2024-07-25 | Stifel | $85.00 | $70 | Hold |
| 2024-07-25 | Canaccord Genuity | $85.00 | $77.0000 | Hold |
| 2024-07-25 | Piper Sandler | $88.00 | $73 | Neutral |
| 2024-07-25 | B of A Securities | $105.0000 | $75 | Neutral |
| 2024-07-25 | JP Morgan | $105.0000 | $72.0000 | Neutral |
| 2024-07-25 | Baird | $102.0000 | $70 | Neutral |
| 2024-07-25 | Oppenheimer | $100.00 | $90 | Outperform |
| 2024-07-16 | Truist Securities | $105.0000 | $110 | Buy |
| 2024-07-10 | Citigroup | $105.00 | $106.0000 | Buy |
| 2024-07-02 | Evercore ISI Group | $89.00 | $91 | In-Line |
| 2024-05-30 | Goldman Sachs | $107.0000 | Buy | |
| 2024-05-22 | Citigroup | $98.00 | $105.0000 | Buy |
| 2024-05-14 | Deutsche Bank | $86.0000 | $103 | Buy |
| 2024-05-07 | Barclays | $100.0000 | $101.0000 | Overweight |
| 2024-04-26 | Canaccord Genuity | $86.0000 | $85.0000 | Hold |
| 2024-04-26 | Piper Sandler | $85.0000 | $88 | Neutral |
| 2024-04-26 | Stifel | $83.00 | $85 | Hold |
| 2024-04-26 | Evercore ISI Group | $92.00 | $89 | In-Line |
| 2024-04-26 | Wells Fargo | $94.00 | $99 | Overweight |
| 2024-04-15 | RBC Capital | $95.00 | $101.0000 | Outperform |
| 2024-04-11 | Mizuho | $95.00 | $105 | Buy |
| 2024-04-04 | Evercore ISI Group | $86.0000 | $92 | In-Line |
| 2024-04-03 | Citigroup | $90.0000 | $98.0000 | Neutral |
Edwards Lifesciences stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2025-03-28 | $71.37 | 0.39% |
| 2025-03-31 | $71.82 | 0.63% |
| 2025-04-01 | $71.02 | -1.11% |
| 2025-04-02 | $72.07 | 1.49% |
| 2025-04-03 | $71.49 | -0.81% |
EW : Long term Edwards Lifesciences stock forecast for 2025 - 2026 - 2030 - 2035
Forecast for 2025 Apr. is $73.62 , for 2026 Mar. is $98.68 , for 2029 Mar. is $73.62 , for 2030 Mar. is $76.80 , for 2034 Mar. is $109.65 , and for 2035 Mar. is $70.93.
EW : Edwards Lifesciences stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Apr. | $73.62 | 3.56% |
| 2025 May. | $76.42 | 3.80% |
| 2025 Jun. | $78.77 | 3.07% |
| 2025 Jul. | $80.54 | 2.25% |
| 2025 Aug. | $81.80 | 1.56% |
| 2025 Sep. | $83.11 | 1.60% |
| 2025 Oct. | $84.88 | 2.13% |
| 2025 Nov. | $87.22 | 2.75% |
| 2025 Dec. | $90.01 | 3.21% |
EW : Edwards Lifesciences stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $93.07 | 3.40% |
| 2026 Feb. | $96.02 | 3.17% |
| 2026 Mar. | $98.68 | 2.77% |
| 2026 Apr. | $101.17 | 2.52% |
| 2026 May. | $103.65 | 2.45% |
| 2026 Jun. | $106.18 | 2.45% |
| 2026 Jul. | $108.92 | 2.58% |
| 2026 Aug. | $112.28 | 3.09% |
| 2026 Sep. | $115.70 | 3.04% |
| 2026 Oct. | $118.82 | 2.70% |
| 2026 Nov. | $121.92 | 2.61% |
| 2026 Dec. | $125.03 | 2.55% |
EW : Edwards Lifesciences stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $127.79 | 2.21% |
| 2027 Feb. | $129.48 | 1.32% |
| 2027 Mar. | $129.47 | -0.00% |
| 2027 Apr. | $129.36 | -0.09% |
| 2027 May. | $131.25 | 1.46% |
| 2027 Jun. | $132.04 | 0.60% |
| 2027 Jul. | $141.14 | 6.89% |
| 2027 Aug. | $144.14 | 2.13% |
| 2027 Sep. | $145.38 | 0.87% |
| 2027 Oct. | $146.45 | 0.73% |
| 2027 Nov. | $147.31 | 0.59% |
| 2027 Dec. | $147.83 | 0.36% |
EW : Edwards Lifesciences stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $147.92 | 0.06% |
| 2028 Feb. | $147.37 | -0.37% |
| 2028 Mar. | $146.03 | -0.91% |
| 2028 Apr. | $143.70 | -1.59% |
| 2028 May. | $140.40 | -2.30% |
| 2028 Jun. | $136.12 | -3.05% |
| 2028 Jul. | $130.95 | -3.80% |
| 2028 Aug. | $124.76 | -4.73% |
| 2028 Sep. | $117.58 | -5.75% |
| 2028 Oct. | $108.92 | -7.36% |
| 2028 Nov. | $99.67 | -8.49% |
| 2028 Dec. | $91.04 | -8.65% |
EW : Edwards Lifesciences stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $83.81 | -7.94% |
| 2029 Feb. | $78.03 | -6.89% |
| 2029 Mar. | $73.62 | -5.66% |
| 2029 Apr. | $70.52 | -4.22% |
| 2029 May. | $68.77 | -2.47% |
| 2029 Jun. | $68.26 | -0.74% |
| 2029 Jul. | $68.60 | 0.50% |
| 2029 Aug. | $69.37 | 1.13% |
| 2029 Sep. | $70.26 | 1.28% |
| 2029 Oct. | $71.01 | 1.07% |
| 2029 Nov. | $71.70 | 0.97% |
| 2029 Dec. | $73.25 | 2.16% |
EW : Edwards Lifesciences stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $74.52 | 1.73% |
| 2030 Feb. | $75.18 | 0.89% |
| 2030 Mar. | $76.80 | 2.16% |
| 2030 Apr. | $81.01 | 5.48% |
| 2030 May. | $87.99 | 8.62% |
| 2030 Jun. | $90.77 | 3.16% |
| 2030 Jul. | $90.18 | -0.66% |
| 2030 Aug. | $87.80 | -2.64% |
| 2030 Sep. | $85.21 | -2.95% |
| 2030 Oct. | $83.85 | -1.60% |
| 2030 Nov. | $84.01 | 0.20% |
| 2030 Dec. | $85.27 | 1.50% |
EW : Edwards Lifesciences stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $87.28 | 2.36% |
| 2031 Feb. | $89.49 | 2.52% |
| 2031 Mar. | $91.56 | 2.32% |
| 2031 Apr. | $93.45 | 2.06% |
| 2031 May. | $95.23 | 1.91% |
| 2031 Jun. | $97.01 | 1.87% |
| 2031 Jul. | $98.83 | 1.88% |
| 2031 Aug. | $100.60 | 1.78% |
| 2031 Sep. | $102.20 | 1.59% |
| 2031 Oct. | $103.63 | 1.41% |
| 2031 Nov. | $104.99 | 1.31% |
| 2031 Dec. | $106.36 | 1.31% |
EW : Edwards Lifesciences stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $107.83 | 1.38% |
| 2032 Feb. | $109.43 | 1.48% |
| 2032 Mar. | $111.19 | 1.61% |
| 2032 Apr. | $113.21 | 1.81% |
| 2032 May. | $115.64 | 2.15% |
| 2032 Jun. | $119.01 | 2.91% |
| 2032 Jul. | $125.77 | 5.68% |
| 2032 Aug. | $133.41 | 6.07% |
| 2032 Sep. | $137.14 | 2.80% |
| 2032 Oct. | $139.42 | 1.67% |
| 2032 Nov. | $141.11 | 1.21% |
| 2032 Dec. | $142.21 | 0.78% |
EW : Edwards Lifesciences stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $142.86 | 0.45% |
| 2033 Feb. | $143.38 | 0.37% |
| 2033 Mar. | $143.87 | 0.34% |
| 2033 Apr. | $144.23 | 0.25% |
| 2033 May. | $144.35 | 0.08% |
| 2033 Jun. | $144.14 | -0.14% |
| 2033 Jul. | $143.55 | -0.42% |
| 2033 Aug. | $142.42 | -0.78% |
| 2033 Sep. | $140.63 | -1.25% |
| 2033 Oct. | $138.12 | -1.78% |
| 2033 Nov. | $134.78 | -2.42% |
| 2033 Dec. | $130.16 | -3.42% |
EW : Edwards Lifesciences stock forecast for 2034
| Date | Price Target | Change |
|---|---|---|
| 2034 Jan. | $124.40 | -4.43% |
| 2034 Feb. | $117.65 | -5.42% |
| 2034 Mar. | $109.65 | -6.80% |
| 2034 Apr. | $100.72 | -8.15% |
| 2034 May. | $91.88 | -8.78% |
| 2034 Jun. | $83.88 | -8.70% |
| 2034 Jul. | $77.23 | -7.93% |
| 2034 Aug. | $72.12 | -6.61% |
| 2034 Sep. | $68.51 | -5.01% |
| 2034 Oct. | $66.35 | -3.14% |
| 2034 Nov. | $65.69 | -1.00% |
| 2034 Dec. | $66.33 | 0.97% |
EW : Edwards Lifesciences stock forecast for 2035
| Date | Price Target | Change |
|---|---|---|
| 2035 Jan. | $67.73 | 2.12% |
| 2035 Feb. | $69.35 | 2.38% |
| 2035 Mar. | $70.93 | 2.29% |
Financial Data for Edwards Lifesciences stock
Frequently Asked Questions about Edwards Lifesciences stock forecast
Is Edwards Lifesciences a good long term stock?
From Edwards Lifesciences stock forecast , Edwards Lifesciences (EW) stock can be a good investment choice. According to AIPickup, the Edwards Lifesciences stock price forecast for 2025 Apr. is $73.6237020608276 From Edwards Lifesciences stock forecast , Edwards Lifesciences (EW) stock can be a good investment choice. According to AIPickup, the Edwards Lifesciences stock price forecast for 2026 Mar. is $98.6823160129287 From Edwards Lifesciences stock forecast , Edwards Lifesciences (EW) stock can be a good investment choice. According to AIPickup, the Edwards Lifesciences stock price forecast for 2029 Mar. is $73.6201618368088 From Edwards Lifesciences stock forecast , Edwards Lifesciences (EW) stock can be a good investment choice. According to AIPickup, the Edwards Lifesciences stock price forecast for 2030 Mar. is $76.8038325041118 From Edwards Lifesciences stock forecast , Edwards Lifesciences (EW) stock can be a good investment choice. According to AIPickup, the Edwards Lifesciences stock price forecast for 2034 Mar. is $109.651971862937 From Edwards Lifesciences stock forecast , Edwards Lifesciences (EW) stock cannot be a good investment choice. According to AIPickup, the Edwards Lifesciences stock price forecast for 2035 Mar. is $70.934513736082
Is Edwards Lifesciences stock overvalued?
Edwards Lifesciences (EW) stock is expected to go UP . Therefore, AIPickup would say that Edwards Lifesciences (EW) stock is NOT overvalued.
Will Edwards Lifesciences stock price go up?
Yes. The Edwards Lifesciences stock price forecast for 2026 Mar. is $98.6823160129287
Is Edwards Lifesciences stock a good buy now?
Since closing price on 2025-03-26 is $71.0899963378906 and forecast for 2026 Mar. is $98.68, Edwards Lifesciences stock is a good 1 year investment.
14 Days Historical Data for Edwards Lifesciences stock price
| Date | Close | Open | Low | High |
|---|---|---|---|---|
| EW stock price for 2025-03-07 | $70.33 | $70.83 | $69.33 | $71.53 |
| EW stock price for 2025-03-10 | $68.53 | $69.48 | $68.18 | $69.97 |
| EW stock price for 2025-03-11 | $68.39 | $68.24 | $67.80 | $69.02 |
| EW stock price for 2025-03-12 | $68.51 | $69.11 | $68.33 | $70.74 |
| EW stock price for 2025-03-13 | $67.95 | $68.74 | $67.32 | $68.92 |
| EW stock price for 2025-03-14 | $69.29 | $68.43 | $67.78 | $69.66 |
| EW stock price for 2025-03-17 | $70.63 | $68.86 | $68.64 | $71.05 |
| EW stock price for 2025-03-18 | $70.34 | $70.39 | $70.02 | $71.08 |
| EW stock price for 2025-03-19 | $70.90 | $70.38 | $69.96 | $71.20 |
| EW stock price for 2025-03-20 | $70.95 | $70.67 | $70.16 | $71.85 |
| EW stock price for 2025-03-21 | $70.46 | $70.62 | $69.82 | $70.94 |
| EW stock price for 2025-03-24 | $71.35 | $70.83 | $70.63 | $72.24 |
| EW stock price for 2025-03-25 | $71.24 | $71.46 | $70.78 | $72.29 |
| EW stock price for 2025-03-26 | $71.09 | $71.02 | $70.41 | $71.42 |